Direct-to-Consumer Genetic Testing Market Size is projected to reach USD 6.68 billion by 2031, growing at a CAGR of 17.30%: Straits Research

New York, United States, June 12, 2023 (GLOBE NEWSWIRE) -- The collective term for genetic tests marketed directly to consumers is "direct-to-consumer genetic testing" (DTC-GT). Without the assistance of a healthcare professional or health insurer, DTC-GT tests are sold directly to consumers. There are numerous ways to utilize genetic testing data, each with its revenue model. The genomic data can be used for nutrigenomics or individual health planning, including genetic tests to determine disease risk. Customers can also obtain comprehensive genomic tests by utilizing the third-party platform as a service. Direct-to-consumer genetic testing, which provides individuals with access to their genetic information, is also referred to as direct-access genetic testing, DTC genetic testing, at-home genetic testing, and home DNA testing.

                                                                                                                   

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/direct-to-consumer-genetic-testing-market/request-sample 

Growing Number of Direct-to-Consumer Genetic Tests Drives the Global Market

Due to the rapidly declining cost of DNA sequencing, more genetic tests are now than ever. Recently, these tests have become the standard of care for oncology and pregnant patients. In 2018, Concert Genetics and the Department of Clinical Pharmacy at the University of California, San Francisco, published a study revealing approximately 75,000 genetic tests and 10,000 test types available. The rise in direct-to-consumer genetic testing among consumers results from the sales and marketing strategies employed by the market's major players. The major players, 23andme, Inc. and Ancestry DNA, have access to the largest database of human genetic data and provide wellness, wellness risk, and genealogy reports. According to MIT Technology Review, the cumulative number of genetic tests conducted in 2019 will exceed 26 million, increasing the demand for automated DNA extraction in the coming years and propelling the market growth.

Massive Scope for the Adoption of Genomic-Based Medicine in Emerging Nations Creates Tremendous Opportunities

Accessibility to high-quality diagnostic tests, particularly molecular tests for genetic disorders, is a global priority. Despite their significant advancements and subsequent adoption as standard medical procedures, people in low-income countries still require access to biomarker-based tests. This restriction may prevent them from receiving life-saving treatments, thereby decreasing the likelihood of effectively halting the spread of infectious diseases. In developing nations, inadequate funding and an uneven distribution of diagnostic laboratories are problems. Using tests that can be administered without laboratory assistance could significantly increase accessibility. The shortage of high-quality test portfolios is primarily attributable to several obstacles, such as a lack of durability and affordability, exacerbated by reduced performance due to environmental challenges, such as high temperatures and dust. Nonetheless, most of the industry's key players view these emerging regions as highly untapped, making them ideal for expanding their business and creating significant expansion opportunities in the market.

Report Scope

Report Metric	Details
Market Size by 2031	USD 6,686.46 million
Market Size in 2022	USD 1,590.43 million
CAGR	17.30%
Historical Data	2020-2021
Base Year	2022
Forecast Period	2023-2031
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product Type, Technology, Distribution Channel
Geographies Covered	North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors	23andme, Inc., Color Genomics, 24Genetics, Ancestry.com, LLC, Easy DNA, My Heritage Ltd., DNAfit
Key Market Opportunities	Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
Key Market Drivers	Growing Number of Direct-to-Consumer Genetic Tests Decreasing the Cost of Sequencing

Buy Now Full Report @ https://straitsresearch.com/buy-now/direct-to-consumer-genetic-testing-market 

Regional Analysis

North America is the most significant global direct-to-consumer genetic testing market shareholder and is anticipated to exhibit a CAGR of 17.23% during the forecast period. The U.S. market dominates the direct-to-consumer genetic testing landscape in North America. In this region, key industry players such as Ancestry.com, 23andMe, and Family Tree DNA have been significant market drivers for direct-to-consumer genetic testing. The market for direct-to-consumer genetic testing has also been driven by factors such as the availability of funding, a robust economy, and favorable market conditions for scientific innovations. In addition, the expanding use of personal genomics and the burgeoning consumer interest in ancestry and health-based DTC-GT also contribute to expanding the North American market. Developing novel genetic tests that could predict potential allergies, different responses to medication, and associated risks of genetic diseases such as neurofibromatosis, cancer, and spinal muscular atrophy is another factor driving market growth in North America.

Europe is estimated to exhibit a CAGR of 16.82% over the forecast period. Since its inception, the DTC genetic testing market in Europe has been expanding. Several European nations are persistently working to increase vaccination rates throughout the continent. Europe holds the second-largest market share in revenue on the global market for direct-to-consumer (DTC) genetic testing due to rising healthcare expenditures and a regional emphasis on immunizing and eradicating infectious diseases. There currently needs to be more direct-to-consumer genetic testing companies in Europe. Nevertheless, national bioethics committees in countries such as Belgium, France, and Portugal have addressed the issue. In addition, numerous national organizations issue additional statements. The European market for direct-to-consumer genetic testing is ripe for local, new entrants capable of rapidly promoting and commercializing DTC genetic tests across the population. This opportunity is bolstered by the funding that direct-to-consumer companies receive to conduct genetic testing and publish results via online portals.

Key Highlights

• The global direct-to-consumer genetic testing market size is estimated to reach USD 6,686.46 million by 2031, growing at a CAGR of 17.30% during the forecast period (2023–2031).
• Based on product type, the global direct-to-consumer genetic testing market is segmented into ancestry, health and wellness, and entertainment. The ancestry segment owns the highest market share and is predicted to exhibit a CAGR of 16.68% during the forecast period.
• Based on technology, the global direct-to-consumer genetic testing market is divided into single nucleotide polymorphisms (SNPs), targeted analysis, and whole genome sequencing (WGS). The single nucleotide polymorphisms (SNPs) segment is responsible for the largest market share and is estimated to grow at a CAGR of 17.23% over the forecast period.
• Based on the distribution channel, the global direct-to-consumer genetic testing market is divided into online channels and over-the-counter (OTC) sales. The online channel segment is responsible for the highest market share and is anticipated to exhibit a CAGR of 17.67% over the forecast period.
• North America is the most significant global direct-to-consumer genetic testing market shareholder and is anticipated to exhibit a CAGR of 17.23% during the forecast period.

Competitors in Direct-to-Consumer Genetic Testing Market

• 23andme Inc.
• Color Genomics
• 24Genetics
• Ancestry.com LLC
• Easy DNA
• My Heritage Ltd.
• DNAfit

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/direct-to-consumer-genetic-testing-market/request-sample 

 

Segmentation of Direct-to-Consumer Genetic Testing Market

By Product Type

• Ancestry
• Health and Wellness
• Entertainment

By Technology

• Targeted Analysis
• Single Nucleotide Polymorphisms (SNPs)
• Whole Genome Sequencing (WGS)

By Distribution Channel

• Online Channel
• Over-the-Counter Channel

By Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

TABLE OF CONTENT

1. Executive Summary
2. Research Scope & Segmentation
   1. Research Objectives
   2. Market Definition
   3. Limitations & Assumptions
   4. Market Scope & Segmentation
   5. Currency & Pricing Considered
3. Market Opportunity Assessment
   1. Emerging Regions / Countries
   2. Emerging Companies
   3. Emerging Applications / End Use
   4. Investment Landscape
   5. New Business Models / Revenue Streams
   6. TAM
4. Market Trends
   1. Drivers
   2. Market Warning Factors
   3. Latest Macro Economic Indicators
   4. Geopolitical Impact
   5. Human Factors
   6. Technology Factors
5. Market Assessment
   1. Porters Five Forces Analysis
   2. Value Chain Analysis
   3. Sales And Distribution Channel Analysis
   4. Case Study Analysis
   5. Patent Analysis
   6. M & A Agreements & Collabration Analysis
6. ESG TRENDS
7. Global Direct-To-Consumer Genetic Testing Market Size Analysis
   1. Global Direct-To-Consumer Genetic Testing Market Introduction
   2. By Product Type
      1. Introduction
         1. Product Type By Value
      2. Ancestry
         1. By Value
      3. Health And Wellness
         1. By Value
      4. Entertainment
         1. By Value
   3. By Technology
      1. Introduction
         1. Technology By Value
      2. Targeted Analysis
         1. By Value
      3. Single Nucleotide Polymorphisms (SNPs)
         1. By Value
      4. Whole Genome Sequencing (WGS)
         1. By Value
   4. By Distribution Channel
      1. Introduction
         1. Distribution Channel By Value
      2. Online Channel
         1. By Value
      3. Over-The-Counter Channel
         1. By Value
8. North America Market Analysis
   1. Introduction
   2. By Product Type
      1. Introduction
         1. Product Type By Value
      2. Ancestry
         1. By Value
      3. Health And Wellness
         1. By Value
      4. Entertainment
         1. By Value
   3. By Technology
      1. Introduction
         1. Technology By Value
      2. Targeted Analysis
         1. By Value
      3. Single Nucleotide Polymorphisms (SNPs)
         1. By Value
      4. Whole Genome Sequencing (WGS)
         1. By Value
   4. By Distribution Channel
      1. Introduction
         1. Distribution Channel By Value
      2. Online Channel
         1. By Value
      3. Over-The-Counter Channel
         1. By Value
   5. U.S.
   6. Canada
9. Europe Market Analysis
   1. Introduction
   2. By Product Type
      1. Introduction
         1. Product Type By Value
      2. Ancestry
         1. By Value
      3. Health And Wellness
         1. By Value
      4. Entertainment
         1. By Value
   3. By Technology
      1. Introduction
         1. Technology By Value
      2. Targeted Analysis
         1. By Value
      3. Single Nucleotide Polymorphisms (SNPs)
         1. By Value
      4. Whole Genome Sequencing (WGS)
         1. By Value
   4. By Distribution Channel
      1. Introduction
         1. Distribution Channel By Value
      2. Online Channel
         1. By Value
      3. Over-The-Counter Channel
         1. By Value
   5. U.K.
   6. Germany
   7. France
   8. Spain
   9. Italy
   10. Russia
   11. Nordic
   12. Benelux
   13. Rest Of Europe
10. APAC Market Analysis
    1. Introduction
    2. By Product Type
       1. Introduction
          1. Product Type By Value
       2. Ancestry
          1. By Value
       3. Health And Wellness
          1. By Value
       4. Entertainment
          1. By Value
    3. By Technology
       1. Introduction
          1. Technology By Value
       2. Targeted Analysis
          1. By Value
       3. Single Nucleotide Polymorphisms (SNPs)
          1. By Value
       4. Whole Genome Sequencing (WGS)
          1. By Value
    4. By Distribution Channel
       1. Introduction
          1. Distribution Channel By Value
       2. Online Channel
          1. By Value
       3. Over-The-Counter Channel
          1. By Value
    5. China
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest Of Asia-Pacific
11. Middle East And Africa Market Analysis
    1. Introduction
    2. By Product Type
       1. Introduction
          1. Product Type By Value
       2. Ancestry
          1. By Value
       3. Health And Wellness
          1. By Value
       4. Entertainment
          1. By Value
    3. By Technology
       1. Introduction
          1. Technology By Value
       2. Targeted Analysis
          1. By Value
       3. Single Nucleotide Polymorphisms (SNPs)
          1. By Value
       4. Whole Genome Sequencing (WGS)
          1. By Value
    4. By Distribution Channel
       1. Introduction
          1. Distribution Channel By Value
       2. Online Channel
          1. By Value
       3. Over-The-Counter Channel
          1. By Value
    5. UAE
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest Of MEA
12. LATAM Market Analysis
    1. Introduction
    2. By Product Type
       1. Introduction
          1. Product Type By Value
       2. Ancestry
          1. By Value
       3. Health And Wellness
          1. By Value
       4. Entertainment
          1. By Value
    3. By Technology
       1. Introduction
          1. Technology By Value
       2. Targeted Analysis
          1. By Value
       3. Single Nucleotide Polymorphisms (SNPs)
          1. By Value
       4. Whole Genome Sequencing (WGS)
          1. By Value
    4. By Distribution Channel
       1. Introduction
          1. Distribution Channel By Value
       2. Online Channel
          1. By Value
       3. Over-The-Counter Channel
          1. By Value
    5. Brazil
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest Of LATAM
13. Competitive Assessment
    1. Adoption Matrix
    2. Direct-To-Consumer Genetic Testing Market Share By Manufacturers
    3. Direct-To-Consumer Genetic Testing Market Ranking By Revenue For Manufacturers
    4. Average Price By Manufacturers
    5. Vendor Footprint Analysis
14. Market Players Assessment
    1. 23andme Inc.
       1. Overview
       2. Business Information
       3. Revenue
       4. ASP
       5. Gross Margin
       6. Swot Analysis
       7. Recent Developmments
    2. Color Genomics
    3. 24Genetics
    4. Ancestry.Com
    5. LLC
    6. Easy DNA
    7. My Heritage Ltd.
    8. DNAfit
    9. Others.
15. Research Methodology
    1. Research Data
       1. Secondary Data
          1. Major Secondary Sources
          2. Key Data From Secondary Sources
       2. Primary Data
          1. Key Data From Primary Sources
          2. Breakdown Of Primaries
       3. Secondary And Primary Research
          1. Key Industry Insights
    2. Market Size Estimation
       1. Bottom-Up Approach
       2. Top-Down Approach
       3. Market Projection
    3. Research Assumptions
       1. Assumptions
    4. Limitations
    5. Risk Assessment
16. APPENDIX
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
17. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/direct-to-consumer-genetic-testing-market/toc

Recent Development

• In July 2022, Genetic Technologies Limited (ASX: GTG) is pleased to reveal that it has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA.

• In July 2022, 1health.io Inc., an industry-leading software company that enables diagnostic laboratories to expand their testing in the clinical and direct-to-consumer markets quickly and securely, collaborated with Apollo Health Group to bring Apollo's specialized high-performing NGS tests, like pharmacogenetics screenings (PGx) and hereditary cancer genetic screenings (CGx), to the broader clinical market.

News Media

Global Direct-to-Consumer Genetic Testing Market Extends at a Healthy CAGR of 17.30% by 2031

Global Preimplantation Genetic Testing Market Grows Steadily at a CAGR of 9.75%

Increasing Awareness about Early Cancer Detection Spurs the Global Cancer Genetic Testing Market at a Staggering CAGR of 11.66%

Preimplantation Genetic Testing Market to Reach USD 465.1 Million by 2026 at a CAGR of 8.7%

Have a Look at the Related Research Report

LAMEA Genetic Testing Market is Projected to Reach USD 933 Million by 2030, Growing at a CAGR of 8.30%

North America Genetic Testing Market to Grow with a CAGR of 12.4% through 2030

Preimplantation Genetic Testing Market: Information by Procedure Type (Preimplantation Genetic Diagnosis), Technology (Validation Biomarkers), and Region — Forecast till 2030

Genetic Testing Market: Information by Type (Carrier Testing, Diagnostic Testing), Technology (Cytogenetic Testing), Application (Cancer Diagnosis), and Region — Forecast till 2030

Cancer Genetic Testing Market: Information by Type (Cytogenetic Testing, DNA Sequencing), Application (Lung Cancer), End-Users (Hospitals and Clinics), and Regions—Forecast till 2029

About Straits Research Pvt. Ltd.

StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)

+44 208 068 9665 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter